Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: J Neurosci Res. 2010 Oct;88(13):2976–2990. doi: 10.1002/jnr.22449

Fig. 2.

Fig. 2

UcnII protects against gentamicin-induced ROS formation. Gentamicin, an aminoglycoside and well-known ototoxic agent, induces significant ROS generation over background (second bar). Pretreat-ment for 1 hr with UcnII, which specifically activates CRF2, protects cells against gentamicin-induced ROS formation (third bar), by normalizing the ROS levels to control values. *P < 0.05, **P < 0.01.